Enanta Pharma (ENTA) Stock Price, Quote, News & History

Comments

Enanta Pharmaceuticals Inc (ENTA) Stock Price, Quote, News & History

ENTANASDAQ

Trade with Public

$14.11

0.161.15%

At close: Apr 10, 5:00 PM EST

$14.11

N/A

After Hours: Apr 10, 4:00 PM EST

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$13.94

Close

$14.11

Volume / Avg.

227.55K / 187.11K

Day Range

$13.85 - $14.41

52 Wk Range

4.09 - 17.15

Market Cap

$409.46M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

61

Short Interest

8.8%

Days to Cover

15.54

Recent Enanta Pharmaceuticals Inc News

Why Enanta Shares Are Plunging Today

Enanta Pharmaceuticals Inc's (NASDAQ: ENTA) investigational COVID-19 pill, EDP-235, met its primary endpoints of safety and tolerability in its Phase 2 SPRINT trial but yielded

Vandana Singh

Recap Of Friday's Biotech Catalysts - End of The Day Summary

Ragothaman Srinivasan

Enanta Shares Rise On Positive Data From Initial-Stage Covid-19 Study

Enanta Pharmaceuticals (NASDAQ: ENTA) reported positive topline data from a Phase 1 study evaluating the safety, tolerability, and pharmacokinetics (PK) of orally administered single and multiple ascending doses of EDP-235 in healthy adult subjects.

Ragothaman Srinivasan

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-14.17M

Investing Cash Flow (TTM)

-75.85M

Financing Cash Flow (TTM)

42.50M

Free Cash Flow (TTM)

-18.46M

Capital Expenditure (TTM)

-4.29M

Net Change in Cash (TTM)

-47.52M

Analyst Trends and Forecast

1

Nov 25

1

Jan

1

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.3

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$280.68M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

4.85

PB Ratio (TTM)

3.20

Earnings Yield % (TTM)

-22.96%

Earnings Yield % (FWD)

-15.59%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$4.36

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$37.44M

Debt to Equity

0.45

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$13.94

Close

$14.11

Volume / Avg.

227.55K / 187.11K

Day Range

$13.85 - $14.41

52 Wk Range

4.09 - 17.15

Market Cap

$409.46M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

61

Short Interest

8.8%

Days to Cover

15.54

About

Sector

Health Care

Industry

Biotechnology

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development pro...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Enanta Pharma (ENTA) stock?

A

You can purchase shares of Enanta Pharma (NASDAQ:ENTA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Enanta Pharma (ENTA) competitors?

A

Other companies in Enanta Pharma’s space includes: Monopar Therapeutics Inc (NASDAQ:MNPR), Immuneering Corp (NASDAQ:IMRX), Armata Pharmaceuticals Inc (AMEX:ARMP), YD Bio Ltd (NASDAQ:YDES) and Eupraxia Pharmaceuticals Inc (NASDAQ:EPRX).

Q

What is the forecast, or price target, for Enanta Pharma (ENTA) stock?

A

Enanta Pharma has a consensus price target of $18.55.

Q

What is the current price for Enanta Pharma (ENTA)?

A

The stock price for Enanta Pharma (NASDAQ: ENTA) is $14.11 last updated April 10, 2026 at 4:00 PM EDT.

Q

Does Enanta Pharma (ENTA) pay a dividend?

A

There are no upcoming dividends for Enanta Pharma.

Q

When is Enanta Pharma (NASDAQ:ENTA) reporting earnings?

A

Enanta Pharma does not have any upcoming earnings scheduled.

Q

Is Enanta Pharma (ENTA) going to split?

A

There is no upcoming split for Enanta Pharma.

Q

What sector and industry does Enanta Pharma (ENTA) operate in?

A

Enanta Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Monopar Therapeutics Inc

ARMP

YDES

Eupraxia Pharmaceuticals Inc

Century Therapeutics Inc

NASDAQ:IPSC

$2.25

%

Emergent BioSolutions Inc

NYSE:EBS

$7.92

-0.49%

Key Statistics

Open

$13.94

Close

$14.11

Volume / Avg.

227.55K / 187.11K

Day Range

$13.85 - $14.41

52 Wk Range

4.09 - 17.15

Market Cap

$409.46M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

61

Short Interest

8.8%

Days to Cover

15.54

Recent Enanta Pharmaceuticals Inc News

Why Enanta Shares Are Plunging Today

Enanta Pharmaceuticals Inc's (NASDAQ: ENTA) investigational COVID-19 pill, EDP-235, met its primary endpoints of safety and tolerability in its Phase 2 SPRINT trial but yielded

Vandana Singh

Recap Of Friday's Biotech Catalysts - End of The Day Summary

Ragothaman Srinivasan

Enanta Shares Rise On Positive Data From Initial-Stage Covid-19 Study

Enanta Pharmaceuticals (NASDAQ: ENTA) reported positive topline data from a Phase 1 study evaluating the safety, tolerability, and pharmacokinetics (PK) of orally administered single and multiple ascending doses of EDP-235 in healthy adult subjects.

Ragothaman Srinivasan

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-14.17M

Investing Cash Flow (TTM)

-75.85M

Financing Cash Flow (TTM)

42.50M

Free Cash Flow (TTM)

-18.46M

Capital Expenditure (TTM)

-4.29M

Net Change in Cash (TTM)

-47.52M

Analyst Trends and Forecast

1

Nov 25

1

Jan

1

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.3

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$280.68M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

4.85

PB Ratio (TTM)

3.20

Earnings Yield % (TTM)

-22.96%

Earnings Yield % (FWD)

-15.59%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$4.36

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$37.44M

Debt to Equity

0.45

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$13.94

Close

$14.11

Volume / Avg.

227.55K / 187.11K

Day Range

$13.85 - $14.41

52 Wk Range

4.09 - 17.15

Market Cap

$409.46M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

61

Short Interest

8.8%

Days to Cover

15.54

About

Sector

Health Care

Industry

Biotechnology

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development pro...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry